VRUS founder, Raymond Schinazi, says GILD could have bought VRUS for only $300M in 2004: http://www.reuters.com/article/2011/11/22/us-pharmasset-founder-idUSTRE7AL2ES20111122 p.s. The Reuters piece above has a serious factual error.